Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026986 (
myelodysplastic syndrome
)
14,926
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies have indicated the Musashi2/
NUMB
pathway as the key regulator of differentiation in chronic myeloid leukemia; however, a comparison of both gene expressions has not yet been made in
myelodysplastic syndrome
(
MDS
) and in acute myeloid leukemia (AML). We herein, demonstrate a statistically significant down-modulation of
NUMB
expression level in high-risk
MDS
and AML, compared with control individuals. MSI2 expression was significantly reduced in low and high-risk
MDS
compared with normal control samples.
NUMB
expression was significantly lower than that of MSI2 in both
MDS
and AML patient samples, but no differences in the expression levels for either gene were observed in healthy bone marrow cells. Finally,
NUMB
expression was significantly up-regulated during differentiation of normal and low-risk
MDS
CD34(+) cells through the erythroid lineage. Taken together, results suggest the involvement of
NUMB
in
MDS
erythropoiesis; its down-modulation may have a role in
MDS
progression.
...
PMID:Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients. 2278 12